Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

HighTech Business Decisions’ New Biopharmaceutical Contract Manufacturing Industry Pricing Study Shows Increase in Overall Production Prices

HighTech Business Decisions
Posted on: 25 Aug 16


HighTech Business Decisions has just published its new study: “Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2016.” This 350-page report details both the prices paid by biotechnology companies and prices charged by biopharmaceutical contract manufacturing organizations for large-molecule drug substance production, using both mammalian cell culture and microbial fermentation technologies, at specific bioreactor tank sizes. In addition, this report documents current prices for other services offered by the contract manufacturing organizations, including cell banking, cell-line development, process development, technology transfer, and regulatory support.

William Downey, president of HighTech Business Decisions, explained, “According to the biotechnology and contract manufacturing executives, overall contract manufacturing prices have shown a moderate increase over the past two years as industry supply and demand come into balance. Furthermore, contract manufacturing organizations see higher demand, greater capacity—especially disposable bioreactors, and added regulatory and quality requirements will affect industry pricing. Going forward, most biotechnology executives expect to pay higher prices for production, analytical and development services, and stability and release testing.”

This report provides the reader with over 225 detailed charts and tables covering industry trends, prices, and selected contract terms such as reservation and cancellation fees, change orders, price models and arrangements. In addition to production prices, this report also documents FTE rates paid and charged by major functional areas.

About HighTech Business Decisions

HighTech Business Decisions is a market research and consulting firm specializing in biopharmaceutical contract manufacturing. The company has been producing in-depth public reports and customized benchmarking, market analysis and customer loyalty programs for over fifteen years. Visit us at

View source version on

For more information:

Editor's Details

Mike Wood

Last updated on: 27/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.